The 100 Most Cited Kluver-Bucy Research Articles: A Bibliometric Analysis von Janku, Cynthia, Engel, Priya V, Patel, Kisan, Giraldo, Elias

Volltext

An Introduction to Harm Reduction for Medical Students: Addressing Stigma Through an Interactive Preclerkship Lecture von Janku, Cynthia, De Sa, Lauren, Daniyan, Adegbemisola

Volltext

Paradoxical Hyperreflexia in a Patient With Classic Guillain-Barré Syndrome von Nguyen, Quang, Janku, Cynthia, Tan, Michelle, Hunsucker, Rachel, Li, Jeffrey J, Salahuddin, Tehmina

Volltext

The Effect of Nanodisc MSP Belt Proteins on the Incorporated Lipid Bilayer von Steele, Harmen B.B., Stipe, Kristian, Janku, Cynthia, Terwilliger, Michelle C., Bowler, Bruce E., Ross, J.B. Alexander

Volltext

Paradoxical Hyperreflexia in a Patient With Classic Guillain-Barré Syndrome von Nguyen, Quang, Janku, Cynthia, Tan, Michelle, Hunsucker, Rachel, Li, Jeffrey J, Salahuddin, Tehmina

Volltext

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants von Smith, Bryan D., Kaufman, Michael D., Lu, Wei-Ping, Gupta, Anu, Leary, Cynthia B., Wise, Scott C., Rutkoski, Thomas J., Ahn, Yu Mi, Al-Ani, Gada, Bulfer, Stacie L., Caldwell, Timothy M., Chun, Lawrence, Ensinger, Carol L., Hood, Molly M., McKinley, Arin, Patt, William C., Ruiz-Soto, Rodrigo, Su, Ying, Telikepalli, Hanumaiah, Town, Ajia, Turner, Benjamin A., Vogeti, Lakshminarayana, Vogeti, Subha, Yates, Karen, Janku, Filip, Abdul Razak, Albiruni Ryan, Rosen, Oliver, Heinrich, Michael C., Flynn, Daniel L.

Volltext

Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act von Kehl, Kenneth L, Fullmer, Cheryl P, Fu, Siqing, George, Goldy C, Hess, Kenneth R, Janku, Filip, Karp, Daniel D, Kato, Shumei, Kizer, Cynthia K, Kurzrock, Razelle, Naing, Aung, Pant, Shubham, Piha-Paul, Sarina A, Subbiah, Vivek, Tsimberidou, Apostolia M, Hong, David S

Volltext

Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas von Groisberg, Roman, Hong, David S, Holla, Vijaykumar, Janku, Filip, Piha-Paul, Sarina, Ravi, Vinod, Benjamin, Robert, Kumar Patel, Shreyas, Somaiah, Neeta, Conley, Anthony, Ali, Siraj M, Schrock, Alexa B, Ross, Jeffrey S, Stephens, Philip J, Miller, Vincent A, Sen, Shiraj, Herzog, Cynthia, Meric-Bernstam, Funda, Subbiah, Vivek

Volltext

Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications von Jiang, Yunyun, Janku, Filip, Subbiah, Vivek, Angelo, Laura S, Naing, Aung, Anderson, Peter M, Herzog, Cynthia E, Fu, Siqing, Benjamin, Robert S, Kurzrock, Razelle

Volltext

Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors von Dembla, Vikas, Groisberg, Roman, Hess, Ken, Fu, Siqing, Wheler, Jennifer, Hong, David S., Janku, Filip, Zinner, Ralph, Piha-Paul, Sarina Anne, Ravi, Vinod, Benjamin, Robert S., Patel, Shreyaskumar, Somaiah, Neeta, Herzog, Cynthia E., Karp, Daniel D., Roszik, Jason, Meric-Bernstam, Funda, Subbiah, Vivek

Volltext

Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies von Subbiah, Vivek, Hess, Kenneth R., Khawaja, Muhammad Rizwan, Wagner, Michael J., Tang, Chad, Naing, Aung, Fu, Siqing, Janku, Filip, Piha-Paul, Sarina, Tsimberidou, Apostolia M., Herzog, Cynthia E., Ludwig, Joseph A., Patel, Shreyaskumar, Ravi, Vinod, Benjamin, Robert S., Meric-Bernstam, Funda, Hong, David S.

Volltext

Abstract LB-039: Translational research in a phase I proof-of-concept study supports that DCC-2618 is a pan-KIT inhibitor von Janku, Filip, Razak, Albi, Gordon, Michael, Brooks, David, Flynn, Daniel, Gupta, Anu, Kaufman, Michael, Leary, Cynthia, Smith, Bryan, Westwood, Deb, Somaiah, Neeta, Helman, Elena, Gerstenberger, Eric, Rosen, Oliver, George, Suzanne

Volltext

Outcomes of patients with advanced sarcoma enrolled in clinical trials of pazopanib in combination with histone deacetylase, mTOR, Her2, or MEK inhibitors von Dembla, Vikas, Fu, Siqing, Wheler, Jennifer, Hong, David S., Janku, Filip, Zinner, Ralph, Piha-Paul, Sarina Anne, Ravi, Vinod, Benjamin, Robert S., Patel, Shreyaskumar, Somaiah, Neeta, Herzog, Cynthia E., Karp, Daniel D., Meric-Bernstam, Funda, Subbiah, Vivek

Volltext

Clinical next-generation sequencing in sarcomas von Groisberg, Roman, Hong, David S., Janku, Filip, Piha-Paul, Sarina Anne, Ravi, Vinod, Benjamin, Robert S., Patel, Shreyaskumar, Somaiah, Neeta, Conley, Anthony Paul, Herzog, Cynthia E., Meric-Bernstam, Funda, Subbiah, Vivek

Volltext

Abstract 48: Theranostic profiling of adolescents and young adults (AYA) with advanced fibrolamellar hepatocellular carcinoma identifies aberrant activation of the PI3K/AKT/MTOR si... von Subbiah, Ishwaria M., Janku, Filip, Naing, Aung, Fu, Siqing, Hong, David S., Kaseb, Ahmed O., Herzog, Cynthia, Kurzrock, Razelle, Wolff, Robert A., Subbiah, Vivek

Volltext

Targeted therapies in early-phase trials for the treatment of advanced fibrolamellar hepatocellular carcinoma von Subbiah, Ishwaria Mohan, Subbiah, Vivek, Naing, Aung, Fu, Siqing, Kaseb, Ahmed Omar, Falchook, Gerald Steven, Tan, Dongfeng, Herzog, Cynthia E., Janku, Filip, Kurzrock, Razelle

Volltext

Eliciting early-response signals from first-in-human clinical trials and validation of prognostic scores in aggressive biology bone cancers: The MD Anderson experience von Livingston, John Andrew, Hess, Kenneth R., Fernandez, Joanna Grace, Naing, Aung, Hong, David S., Patel, Shreyaskumar, Anderson, Peter Meade, Benjamin, Robert S., Ludwig, Joseph A., Herzog, Cynthia E., Fu, Siqing, Wheler, Jennifer J., Falchook, Gerald Steven, Tsimberidou, Apostolia Maria, Piha-Paul, Sarina Anne, Janku, Filip, Rohren, Eric, Meric-Bernstam, Funda, Kurzrock, Razelle, Subbiah, Vivek

Volltext

A phase I trial of dabrafenib (BRAF inhibitor) and pazopanib in BRAF- mutated advanced malignancies von Haraldsdottir, Sigurdis, Janku, Filip, Timmers, Cynthia Dawn, Geyer, Susan Michelle, Schaaf, Larry J., Sexton, Jennifer L., Thurmond, Jennifer, Velez Bravo, Vivianne Marie, Stepanek, Vanda M. T., Bertino, Erin Marie, Kendra, Kari Lynn, Mortazavi, Amir, Subbiah, Vivek, Poi, Ming, Phelps, Mitch A., Shah, Manisha H.

Volltext

Outcomes of pediatric cancer patients enrolled in phase 1 clinical trials designed for adults: Experience from a major cancer center von Subbiah, Vivek, Corrales-Medina, Fernando F., Herzog, Cynthia E., Hess, Kenneth R., Egas Bejar, Daniela Elizabeth, Hong, David S., Falchook, Gerald Steven, Anderson, Peter Meade, Nunez, Cesar, Huh, Winston W., Naing, Aung, Tsimberidou, Apostolia Maria, Wheler, Jennifer J., Piha-Paul, Sarina Anne, Janku, Filip, Kleinerman, Eugenie, Kurzrock, Razelle

Volltext

Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: the university of Texas MD and... von Corrales-Medina, Fernando F, Herzog, Cynthia, Hess, Kenneth, Egas-Bejar, Daniela, Hong, David S, Falchook, Gerald, Anderson, Pete, Nunez, Cesar, Huh, Winston W, Naing, Aung, Tsimberidou, Apostolia M, Wheler, Jennifer, Paul, Sarina Piha, Janku, Filip, Kleinerman, Eugenie S, Kurzrock, Razelle, Subbiah, Vivek

Volltext